Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Skye Bioscience, Inc. (NASDAQ:SKYE) fell sharply during Monday's session after the company announced its SBI-100 Ophthalmic Emulsion Phase 2a trial did not achieve target product profile and

BenzingaJun 11 02:10

Argan Reports Strong Earnings, Joins Geron, Planet Labs PBC And Other Big Stocks Moving Higher On Friday

U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Friday.Shares of Argan, Inc. (NYSE:AGX) rose sharply during Friday's session after the company reported better-than-expected fir

BenzingaJun 7 22:19

Why Is Esperion Therapeutics (ESPR) Up 14.2% Since Last Earnings Report?

Yahoo FinanceJun 6 23:31

Esperion's (ESPR) Drugs Get EU Nod for Lowering Heart Risk

Esperion Therapeutics, Inc. ESPR and partner Daiichi Sankyo Europe GmbH announced that the European Commission (EC) has approved a label update for its drugs Nilemdo (bempedoic acid) and Nustendi for the treatment of hypercholesterolemia and to reduce the risk of adverse cardiovascular (CV) events.

Yahoo FinanceMay 24 00:11

Esperion to Participate in Upcoming June Investor Conferences

ANN ARBOR, Mich., May 23, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the following webcasted investor events during the month of May,

GlobeNewswireMay 23 21:00

H.C. Wainwright Maintains Esperion Therapeutics(ESPR.US) With Buy Rating, Maintains Target Price $16

H.C. Wainwright analyst Joseph Pantginis maintains $Esperion Therapeutics(ESPR.US)$ with a buy rating, and maintains the target price at $16.According to TipRanks data, the analyst has a success rate

Futu NewsMay 23 17:34